BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Gan And Lee Pharmaceuticals Reports Phase 3 Success For Once Weekly Insulin GZR4

Gan & Lee Pharmaceuticals announced that two pivotal phase 3 clinical trials, SUPER-1 and SUPER-2, evaluating investigative once-weekly insulin GZR4 In...

April 02, 2026 | News

Samsung Biologics Completes Rockville Facility Acquisition To Expand U.S. Manufacturing Footprint

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishe...

April 02, 2026 | News

NJ Bio And Ajinomoto Bio-Pharma Services Collaborate To Expand AJICAP Access For ADC Development

NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ("Aji Bio‑Pharma"),...

April 02, 2026 | News

Thermo Fisher Scientific Expands Access To Structural Biology With Glacios 3 Cryo TEM

Equipped with the READY System to make structural biology research accessible to more labs Thermo Fisher Scientific, the world leader in serving science, ...

April 01, 2026 | News

Roche Secures FDA Clearance For Cobas c 703 And Cobas ISE Neo Analytical Units

The cobas® c 703 and cobas® ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory work...

April 01, 2026 | News

Hengrui Pharma And Braveheart Bio Report Strong Phase 2 Results For HRS 1893 In Obstructive Hypertrophic Cardiomyopathy

Results of dose-ranging study suggest potential for best-in-class clinical profile across efficacy, safety and ease of use, including s...

April 01, 2026 | News

Centivax Secures 37 Million Dollars In Oversubscribed Financing To Advance Universal Influenza Vaccine

Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets,...

April 01, 2026 | News

Bioptimus Launches STELA Initiative To Build World’s Largest Multimodal Atlas For AI Driven Biology

The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the world model of biology, representing a ~20x increase in scale...

March 27, 2026 | News

GC Biopharma Secures First Latin America Approval For Antibiotic Free Varicella Vaccine

First regulatory clearance in Latin America marks a strategic milestone for regional market expansion- World's first antibiotic-free manufacturing process ...

March 27, 2026 | News

Insilico Medicine Launches PandaClaw To Advance AI Driven Drug Discovery And Target Identification

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced the launch of ...

March 25, 2026 | News

Dizal Reports ZEGFROVY Achieves Superior Progression Free Survival In Phase 3 WU KONG28 Trial For EGFR Exon20ins NSCLC

Treatment with ZEGFROVY® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over pla...

March 23, 2026 | News

Pace Life Sciences Advances Digital Laboratory Operations With Labguru Platform Integration

Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U...

March 20, 2026 | News

DNA Script Expands Global Reach Of SYNTAX Platform Through Strategic Distribution Partnerships

DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, announced it has signed distribution ag...

March 19, 2026 | News

Eccogene Enrols First Patient In Phase 2a MIST Trial Combining ECC4703 With Semaglutide

-Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammat...

March 18, 2026 | News

Stay Connected